In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beijing QL Biopharmaceutical Co.,Ltd

Latest From Beijing QL Biopharmaceutical Co.,Ltd

Chinese RNA Therapy Developers Extend Fundraising Streak Into December

In the latest venture capital and private equity funding deals in China, SanegeneBio, Argo Biopharma and Ausper Biopharma raised a combined $136m on the back of their early-stage small interfering RNA and antisense oligonucleotide assets.

China Deals

Chinese Gene And Cell Therapy, mRNA Developers Raise More Funds In March

Roughly $130m was raised in eight biopharma financings in China over the past months that were backed by venture capital investors.

China Financing
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • QL Biopharmaceutical Australia Pty Ltd
    • QL Biopharma
    • BJ QL Biopharmaceutical Co. Ltd.
UsernamePublicRestriction

Register